1,246 results on '"Sanson, Marc"'
Search Results
102. Supplementary Figure 1 from A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
103. Supplementary Table 1 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
104. Deciphering gliomagenesis from GWAS
105. Précision diagnostique de la spectroscopie mega-press dans la prédiction de la mutation IDH: nos premiers résultats en clinique
106. Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model
107. EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection
108. In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas
109. Evolutionary Trajectories of IDH-Mutant Astrocytoma Identify Molecular Grading Markers Related to Cell Cycling
110. Developmental venous anomaly in adult patients with diffuse glioma: A clinically relevant coexistence?
111. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma
112. Current and future tools for determination and monitoring of isocitrate dehydrogenase status in gliomas
113. Low-intensity Pulsed Ultrasound-mediated Blood-brain Barrier Opening Increases Anti-programmed Death-ligand 1 Delivery and Efficacy in Gl261 Mouse Model
114. LZTR1 mutation mediates oncogenesis through stabilization of EGFR and AXL
115. EPCO-05. DIFFERENTIAL MOLECULAR PROFILING OF IDH WILD TYPE GLIOBLASTOMA SURVIVORS REVEALS THE ASSOCIATION OF NEOANTIGEN QUALITY WITH EXCEPTIONAL LONG SURVIVAL
116. EPCO-03. PATHWAY-BASED STRATIFICATION OF GLIOBLASTOMA BY MULTI-OMICS INFORMS SUBTYPE-SPECIFIC MASTER KINASES-PHOSPHOSITE SUBSTRATES
117. BIOM-35. A NEW PRECISION-MEDICINE APPROACH TO PREDICT TUMOR TREATMENT RESPONSE IDENTIFIES IN GLIOBLASTOMA A 17 GENE SIGNATURE PROGNOSTIC OF TMZ RESPONSE AND SURVIVAL WITH ROBUST PREDICTIVE VALUE
118. EXTH-21. DEVELOPMENT OF THERAPEUTIC STRATEGIES BY PATHWAY-BASED MULTI-OMICS APPROACH AND MASTER KINASE ANALYSIS IN GLIOBLASTOMA MULTIFORME
119. EPCO-27. REVEALING TUMOR HETEROGENEITY AND IMMUNE MICROENVIRONMENT IN NF-1 GLIOMA BY SINGLE-CELL GENE EXPRESSION PROFILING
120. CSIG-01. EGFR AND AXL RECEPTOR TYROSINE KINASES DRIVE ONCOGENESIS BY LZTR1 MUTATION
121. PATH-16. THRESHOLDS OF MITOTIC ACTIVITY AND POST-SURGERY RESIDUAL VOLUME ARE INDEPENDENT PROGNOSTIC FACTORS IN ASTROCYTOMA IDH-MUTANT
122. New insights into the Immune TME of adult-type diffuse gliomas
123. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas
124. The influence of cystathionine on neurochemical quantification in brain tumor in vivo magnetic resonance spectroscopy
125. Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma
126. Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma
127. FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas
128. Impact of atopy on risk of glioma: a Mendelian randomisation study
129. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas
130. Abstract 4014: Pathway based analysis of glioblastoma by multi-omics with applications in targeted therapy, prognosis and probabilistic classification
131. Abstract 6140: Transcriptional evolution of glioblastoma reveals changes in bulk composition, mesenchymal sub-type as end-state, and a prognostic association with increased extracellular matrix gene expression
132. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
133. The influence of cystathionine on neurochemical quantification in brain tumor in vivo MR spectroscopy
134. Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial
135. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
136. Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression
137. Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas
138. VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab
139. EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology
140. Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
141. Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials
142. Identification of Candidate Cancer Predisposing Genes by Whole-Exome Sequencing of Families at High-Risk of Glioma
143. Expression and prognostic value of CD80 and CD86 in the tumor microenvironment of newly diagnosed glioblastoma
144. Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma
145. Growth Hormone Receptor (GHR) is overexpressed in low EGFR expressing glioblastoma and promotes tumor growth
146. Pathway based analysis of glioblastoma by multi-omics with applications in targeted therapy, prognosis and probabilistic classification
147. Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
148. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486)
149. Sports d'élite et dopage de masse
150. The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.